-
KN026 Second-line treatment of HER2-expressing gastric cancer or gastroesophageal junction cancer results published in the internationally renowned journal EJC Press Release
Time of Update: 2023-01-05
Suzhou, China, November 23, 2022 – Corning Jerry Biopharmaceuticals (stock code: 9966. HK) and CSPC Pharmaceutical Group (stock code: 1093. HK) HK) jointly announced that the results of the phase II.
-
Domestic AI+ pharmaceutical ushered in a major breakthrough, which will inject a dose of cardiotonic agent into the industry
Time of Update: 2022-09-30
According to "Global AI Pharmaceuticals Entering a New Stage" published by Universal Magazine, from the initial computer-aided drug design (CADD) to today's artificial intelligence drug development (AIDD), AI is currently involved in almost the entire process from drug target discovery to clinical trials.
-
Yanshan Petrochemical's medical polypropylene special material passed the related review of the State Food and Drug Administration
Time of Update: 2022-08-18
The situation of import indicates that Sinopec's medical polypropylene special material will occupy a place in the pharmaceutical packaging material market Recently, Yanshan Petrochemical's medical polypropylene special material B4902 passed the associated review of the State Food and Drug Administration, becoming the first polypropylene infusion bag material that passed the associated review after the reform of China's new drug review system, thus breaking the long-term main dependence of medical polypropylene packaging materials in China.
-
New drug application for RTK inhibitor for the treatment of renal cell carcinoma
Time of Update: 2022-01-10
Recently, Allarity Therapeutics announced that it has submitted a New Drug Application (NDA) to the US FDA to seek approval of the receptor tyrosine kinase (RTK) inhibitor dovitinib for the third-line treatment of renal cell carcinoma (RCC) .
-
China's self-developed ADC new drug approved for marketing for gastric cancer treatment
Time of Update: 2021-06-21
The reporter learned from the Management Committee of Yantai Development Zone on the 10th that China's first original antibody-conjugated drug (ADC) new drug-vedicitumumab, declared by Rongchang Biopharmaceutical (Yantai) Co.
-
The innovative anemia therapy of Baishi Meishi Guibao is to be included in the priority review
Time of Update: 2021-03-12
Transfer from | Two applications for injection at Celgene, a subsidiary of BMS, have been included in the proposed priority review list for the treatment of adult β-Thalassemia patients who need regular infusions of red blood cells (RBCs), according to the latest announcement from the Drug Review Center (CDE) of the State Drug Administration of China.
-
East Sunshine will take 1.5 billion anti-thrombosis drugs
Time of Update: 2020-11-08
On October 30, the official website of the State Drug Administration showed that Dongsan pharmaceutical products to imitate the 4 categories of reported Tegrelo tablets into the administrative approval stage, is expected to be approved in recent days and treated as a review.
-
Gastroenteromema clinically urgently needed drugs will become Hainan's first special batch of take-away drugs
Time of Update: 2020-08-07
Guide: Boao Super Hospital, Chengmei Medical and Reding Pharmaceuticals, have introduced the innovative drug Riptinib to patients in urgent need in China. with the official launch of the General Plan
-
The drug MingJuno acquires Syracuse plus-code solid tumor T cell immunotherapy development
Time of Update: 2020-07-27
On July 20, the company announced the completion of its acquisition of Syracuse Biopharma (Hong Kong) Co., Ltd and obtained a license for EUreka Therapeutics' proprietary ARTEMIS ® antibody TCR techno
-
"Pharmaceutical Speed Reader" step-by-step pharmaceutical sales of Hubei Kyushu Tong equity a number of pharmacies to write off the de-listing
Time of Update: 2020-07-23
Step Pharmaceuticals intends to transfer the shares of Hubei Step Long Kyushu Tong, Heng Rui and Sun Yiyang jointly invested 100 million yuan to set up a new company, and Regenerative Yuan Launch An
-
100% practical rate! The latest dermatology medications and their inquiry guidelines come out
Time of Update: 2020-07-20
infection: refers to local tissue and systemic inflammatory reactions caused by the invasion of the human body by pathogens such as pathogenic microorganisms (bacteria, fungi, viruses, etc.) and parasites tumor: refers to the body under the action of various tumor-causing factors, local tissue cell growth formed by the new organism The common habit of "cancer" refers to all malignant tumors how do to find the relevant drugs?
-
FDA accepts new drug application for new kiozanimod for recurrent multiple sclerosis
Time of Update: 2020-06-09
recently, Celgene announced that the Us FDA (http:// has accepted the application for new drug (http:// (NDA) for the treatment of recurrent multiple sclerosis (RMS), and the European Medicin
-
Treatment of multiple myeloma Sanofi CD38 antibody combination therapy reaches phase 3 clinical end
Time of Update: 2020-05-30
MM is a blood cancer caused by plasma cell cancer in the bone marrow Abnormal plasma cells accumulate in the bone marrow and produce tumors in multiple bones in the body Not only do these cells not fu
-
490000 drug companies were fined for "visible foreign bodies
Time of Update: 2020-02-11
Source: Shandong Provincial Drug Administration Editor: Dandelion Yuxuan On February 10, Shandong food and Drug Administration released the "administrative penalty Information Disclosure - Lu drug adm
-
Research and development daily adamumumab, the first similar drug to be listed in China, won the title of baiaotai
Time of Update: 2019-11-07
Gilead science two new HIV drugs show long-term efficacy; the first adalimumab biological similar drug in China has been approved for marketing; Qilu 2 heavy-duty generic drugs have been approved: alb
